A Cost-Effectiveness Analysis of Biomarkers for Risk Prediction in Atrial Fibrillation

RATIONALE: Atrial fibrillation (AF) is associated with an increased risk of thromboembolism. This risk is currently assessed with scoring systems based on clinical characteristics. However, these tools have limited prognostic performance. Circulating biomarkers are proposed for improved prediction o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakhlé, Gisèle, Tardif, Jean-Claude, Roy, Denis, Rivard, Léna, Samuel, Michelle, Dubois, Anick, LeLorier, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888735/
https://www.ncbi.nlm.nih.gov/pubmed/36720803
http://dx.doi.org/10.1007/s40291-023-00639-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888735/
https://www.ncbi.nlm.nih.gov/pubmed/36720803
http://dx.doi.org/10.1007/s40291-023-00639-0

Ejemplares similares